LncRNA TUG1 facilitates proliferation, invasion and stemness of ovarian cancer cell via miR-186-5p/ZEB1 axis

Cell Biochemistry and Function
Fu-Liang ZhanMei-Zhen Yao


LncRNA TUG1 has been rarely studied in ovarian cancer (OC), our objective was to explore the role of TUG1 in the regulation of malignant phenotypes of OC. Vectors of sh-TUG1, miR-186-5p and pcDNA-ZEB1 were, respectively, constructed and used to infect OC cells. MTT and transwell assays were applied for representing cell proliferation and invasion, respectively. Sphere formation experiment was used to detect the stemness of OC cells. Western blotting and qRT-PCR were employed for detecting the expression of multiple biomarkers on protein and RNA levels, respectively. The luciferase assay was performed to reveal the interactions between miR-186-5p and TUG1 or ZEB1. The silencing of TUG1 and upregulation of miR-186-5p both suppressed the cell proliferation, invasion and cancer stem cell (CSC) properties. Additionally, luciferase assay verified that miR-186-5p directly binds TUG1 and ZEB1. Moreover, overexpression of ZEB1 rescued the impact on the proliferation, invasion and stemness of TUG1 silencing in OC. TUG1 sponges miR-186-5p to release ZEB1 and promotes the proliferation, invasion and stemness of OC cells, suggesting that TUG1 could be a potential therapeutic target for OC therapy. SIGNIFICANCE OF THE STUDY: LncRNA TUG1 coul...Continue Reading


Apr 27, 2005·Trends in Genetics : TIG·Alexander HüttenhoferNorbert Polacek
Jan 21, 2009·Cancer Metastasis Reviews·Otto SchmalhoferThomas Brabletz
Jul 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ahmad M KhalilJohn L Rinn
May 10, 2011·Trends in Cell Biology·Orly Wapinski, Howard Y Chang
Jan 13, 2012·Nature Reviews. Cancer·Long V NguyenConnie J Eaves
Jan 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Man-Tang QiuLin Xu
Jun 4, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Qiang ZhangJie Yao
Jan 10, 2016·Experimental Biology and Medicine·Jun LiQingfang Ma
May 20, 2016·Annual Review of Pathology·Dany Nassar, Cédric Blanpain
Aug 9, 2016·The Journal of Clinical Investigation·Jill E LarsenJohn D Minna
Jun 29, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Tian LanYufeng Yuan
Sep 14, 2017·International Journal of Oncology·Jiaqing CaoXiaolin Li
Oct 7, 2017·Nature Medicine·Eduard Batlle, Hans Clevers
Dec 20, 2017·Cancer Research·Julie CaramelAlain Puisieux
Dec 23, 2017·Asian Journal of Andrology·Octavio Orellana-SerradellHector R Contreras
Dec 25, 2017·Trends in Cell Biology·Chunru Lin, Liuqing Yang
Dec 12, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yu ZhangXiuzhen Han
Jan 7, 2019·Advances in Biological Regulation·Yuri Pekarsky, Carlo M Croce
Mar 3, 2019·Journal of Experimental & Clinical Cancer Research : CR·Shanshan DongYong Zeng
Mar 22, 2019·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zhiqiang ZhangMingyu Fan


Nov 27, 2020·International Journal of Molecular Sciences·Eleonora A BragaNikolay E Kushlinskii

Related Concepts

Biological Markers
Western Blotting
Ovarian Carcinoma
Up-Regulation (Physiology)
Tumor Cells, Malignant
ZEB1 protein, human